These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 9788779

  • 21. Nociceptin/orphanin FQ and [Phe(1)psi(CH2-NH)Gly2]nociceptin(1-13)NH2 modulates the activity of hypothalamic paraventricular nucleus neurons in vitro.
    Shirasaka T, Miyahara S, Takasaki M, Kannan H.
    Brain Res; 2001 Jan 26; 890(1):147-53. PubMed ID: 11164777
    [Abstract] [Full Text] [Related]

  • 22. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
    Leggett JD, Harbuz MS, Jessop DS, Fulford AJ.
    Neuroscience; 2006 Sep 15; 141(4):2051-7. PubMed ID: 16784820
    [Abstract] [Full Text] [Related]

  • 23. Postsynaptic mechanisms underlying responsiveness of amygdaloid neurons to nociceptin/orphanin FQ.
    Meis S, Pape HC.
    J Neurosci; 1998 Oct 15; 18(20):8133-44. PubMed ID: 9763460
    [Abstract] [Full Text] [Related]

  • 24. Antagonistic effects of [Nphe1]nociceptin(1-13)NH2 on nociceptin receptor mediated inhibition of cAMP formation in Chinese hamster ovary cells stably expressing the recombinant human nociceptin receptor.
    Hashimoto Y, Caló G, Guerrini R, Smith G, Lambert DG.
    Neurosci Lett; 2000 Jan 07; 278(1-2):109-12. PubMed ID: 10643813
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Inhibition of cardiovascular activity following microinjection of novel opioid-like neuropeptide nociceptin (orphanin FQ) into the rat rostral ventrolateral medulla.
    Chu X, Xu N, Li P, Mao L, Wang JQ.
    Brain Res; 1999 May 22; 829(1-2):134-42. PubMed ID: 10350539
    [Abstract] [Full Text] [Related]

  • 27. Nociceptin/orphanin FQ: role in nociceptive information processing.
    Yamamoto T, Nozaki-Taguchi N, Sakashita Y, Kimura S.
    Prog Neurobiol; 1999 Apr 22; 57(5):527-35. PubMed ID: 10215100
    [Abstract] [Full Text] [Related]

  • 28. Nociceptin, Phe(1)psi-nociceptin(1 - 13), nocistatin and prepronociceptin(154 - 181) effects on calcium channel currents and a potassium current in rat locus coeruleus in vitro.
    Connor M, Vaughan CW, Jennings EA, Allen RG, Christie MJ.
    Br J Pharmacol; 1999 Dec 22; 128(8):1779-87. PubMed ID: 10588934
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Nociceptin and the ORL-1 ligand [Phe1psi (CH2-NH)Gly2]nociceptin(1-13)NH2 exert anti-opioid effects in the Freund's adjuvant-induced arthritic rat model of chronic pain.
    Bertorelli R, Corradini L, Rafiq K, Tupper J, Calò G, Ongini E.
    Br J Pharmacol; 1999 Nov 22; 128(6):1252-8. PubMed ID: 10578139
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Characterization of the locomotor activity-inhibiting effect of nociceptin/orphanin FQ in mice.
    Rizzi A, Bigoni R, Marzola G, Guerrini R, Salvadori S, Regoli D, Calo' G.
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb 22; 363(2):161-5. PubMed ID: 11218068
    [Abstract] [Full Text] [Related]

  • 34. Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications.
    Chiou LC, Liao YY, Fan PC, Kuo PH, Wang CH, Riemer C, Prinssen EP.
    Curr Drug Targets; 2007 Jan 22; 8(1):117-35. PubMed ID: 17266536
    [Abstract] [Full Text] [Related]

  • 35. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM, Statnick MA, Rorick-Kehn LM, Pintar JE, Ansonoff M, Chen Y, Tucker RC, Ciccocioppo R.
    Pharmacol Ther; 2014 Mar 22; 141(3):283-99. PubMed ID: 24189487
    [Abstract] [Full Text] [Related]

  • 36. Structure-activity studies on nociceptin/orphanin FQ: from full agonist, to partial agonist, to pure antagonist.
    Salvadori S, Guerrini R, Calo G, Regoli D.
    Farmaco; 1999 Mar 22; 54(11-12):810-25. PubMed ID: 10668183
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Nphe(1)]N/OFQ-(1-13)-NH(2) is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K(+) channel activation in rat periaqueductal gray slices.
    Chiou LC, Fan SH, Guerrini R, Caló G.
    Neuropharmacology; 2002 Feb 22; 42(2):246-52. PubMed ID: 11804621
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.